ClinicalTrials.gg
RecruitingNCT05632497INT-METAVOSAUpdated Nov 24, 2025

Alteration of Symbiosis Intestinal Microbiota on Patients With Anorexia Nervosa

An observational study in Anorexia Nervosa, Dysbiosis and Anxious Depression, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris — 4 open to participants now, 5 under way, none of them phase 3. Anorexia Nervosa · Assistance Publique - Hôpitaux de Paris.

Started
2024
with 2 others
Observational
9 of 14
4 open now
Registered
10th of 14
by date

Among the 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris, this one is one of 3 that started in 2024, is one of 9 observational ones, and was the 10th registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

4 of the 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Anorexia Nervosa by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

The purpose of this study will be to study the association between the level of psychic symptomatic of anorexia nervosa (AN) (intensity of food restriction, symptoms of anxiety and depression) and alteration of host environment symbiosis and the mechanism (dysbiosis of intestinal microbiota, increase of intestinal permeability, immunity alteration and low-grade inflammation).

Read the detailed description

This is a monocentric study aims to characterise the intestinal microbiota of anorexia nervosa patients with malnutrition, in comparison with the control subject, by DNA sequencing and metagenomic method. The interaction of intetinal microbiota with the host will be studied through the mecanistic studies and various parameters of alteration of symbiosis (intestinal permeability, inflammation) and their association with psychic symptoms of anorexia nervosa.

The objective of this approche is to have not only a descrition of genomic of material of sampling, but also an overview of its potential functioning.

03

Conditions studied

  • Anorexia Nervosa
  • Dysbiosis
  • Anxious Depression

Keywords

  • Anorexia nervosa
  • Dysbiosis
  • Anxious depression
  • Intestinal microbiota
  • Body mass index
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Hospitalized patients with anorexia nervosa for nutrition rehabilitation in the department of nutrition in Paul Brousse hospital (Villejuif) - APHP.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For patients:

  • Patients aged ≥18 years;
  • Anorexia according to and CIDI (Composite International Diagnostic Interview);
  • (BMI) (P/T2) \< 15;
  • Hospitalization for nutrition rehabilitation;
  • Covered by a health insurance;
  • form signed.

For Healthy Volunteers:

  • Aged ≥18 years;
  • 18.5 \< BMI (P/T2) \< 25;
  • Covered by a health insurance;
  • Informed consent form signed.

Exclusion criteria

Exclusion Criteria:

For patients:

  • Patients no-responding all criteria of or CIDI scores;
  • Taken of antibiotic treatment 2 months / or laxativ 3 weeks before hospitalization;
  • Somatic comorbidity should perturb intestinal microbiota (Crohn's disease, diabetes and all other chronic inflammatory diseases);
  • Patients under guardianship;
  • Patients covered by french AME scheme.

For Healthy Volunteers:

  • Any disease should perturb intestinal microbiota;
  • Recent ponderal variation;
  • Taken of antibiotic treatment 2 months or laxativ 3 weeks before hospitalization;
  • Under guardianship;
  • Covered by french AME scheme.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Anorexia patients

    Hospitalized anorexia patients with body mass index \< 15.

    Biological: Stool and blood samples

  • Healthy controls

    Health volunteers: 18 years or older with body mass index between 18.5 and 25.

    Biological: Stool and blood samples

Interventions

  • BiologicalStool and blood samples

    Stool and blood samples

06

What researchers measure

Primary outcomes

  1. Eating Disorder

    By Eating Disorder Inventory (EDI-3)

    Time frame: at baseline

  2. Anxio-depressive symptomatologic assessements by HAD score

    By HAD score

    Time frame: at baseline

  3. Anxio-depressive symptomatologic assessements by scale of Beck BDI 13

    By scale of Beck BDI 13

    Time frame: at baseline

  4. Anxio-depressive symptomatologic assessements by LSAS Lieboweitz social anxiety scale

    By LSAS Lieboweitz social anxiety scale

    Time frame: at baseline

  5. Anxio-depressive symptomatologic assessements by MOCI

    By Maudsley Obsessions and compulsions inventory (MOCI).

    Time frame: at baseline

  6. Anxio-depressive symptomatologic assessements

    By HAD score, scale of Beck BDI 13, LSAS Lieboweitz social anxiety scale, Maudsley Obsessions and compulsions inventory (MOCI).

    Time frame: at baseline

  7. Physical exercise

    By Global physical activity questionnaire (GPAQ)

    Time frame: at baseline

  8. Biological parameter

    By serum serotonin level

    Time frame: at baseline

Secondary outcomes

  1. Diversity indice

    By index de Sympson et Shannon

    Time frame: at baseline

  2. Intestinal permeability

    By serum zonulin level

    Time frame: at baseline

  3. Immunity alteration

    By interleukins and CRP level

    Time frame: at baseline

  4. Liver function

    Cytolyse analysis in serum

    Time frame: at baseline

  5. BMI

    Calculate of BMI.

    Time frame: at baseline

  6. Body composition

    By Dexa-Scan.

    Time frame: at baseline

  7. Energy expenditure

    Calculate of indirect calorimetry and blood parameters

    Time frame: at baseline

  8. Intestinal functional disorders

    By Francis scale, ,transit with pellets and abdomen x-ray

    Time frame: at baseline

  9. Gene and species richness

    By 16S rRNA gene sequencing method and Metagenomics

    Time frame: at baseline

  10. Circulating mitochondrial DNA copy number

    By telemore size and HLA genotyping

    Time frame: at baseline

  11. Heart damage

    By Left Ventricle Ejection Fraction \< 50% structural parameters on ultrasound

    Time frame: at baseline

  12. Presence of Autistic symptoms (1)

    By Glasgow Sensory Questionnaire GSQ)

    Time frame: at baseline

  13. Presence of Autistic symptoms (2)

    By The SWedish Eating Assessment for Autism spectrum disorders GSQ)

    Time frame: at baseline

  14. EDI

    QUESTIONNAIRE EDI or EATING DISORDER INVENTORY (Eating disorder inventory 2nd edition (EDI-2)

    Time frame: at baseline

  15. Eating Disorder Diagnostic

    By Eating Disorder Diagnostic Scale (EDDS)-DSM-5 VERSION (2015 Wiley Periodicals)

    Time frame: at baseline

  16. Eating behaviors assessment

    By the Detail and Flexibility Questionnaire (DFlex).

    Time frame: at baseline

07

Study locations

1 of 1 sites recruiting
  • Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)
    Villejuif, 94800, France
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Sep 2026, 28 months after the start.

Of 56 non-industry observational studies under Anorexia Nervosa, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 72. This study's planned 28 months is below that.

Counting every sponsor, half of 56 studies reached it within 38 months; a quarter within 16 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2022
First posted
Nov 30, 2022
StartActual
May 23, 2024
Primary completionEst.
Sep 2026
CompletionEst.
Oct 2026
Last update
Nov 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05632497
Collaborators
Fondation de France
Responsible party
Sponsor
First posted
Nov 30, 2022
Start date
May 23, 2024
Primary completion
Sep 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Nov 24, 2025

Study contacts

Mouna HANACHI GUIDOUM, MD
Contact
mouna.hanachi@aphp.fr
+ 33 6 70 39 42 37
Joël DORE
Contact
joel.dore@jouy.inrae.fr
+ 33 1 34 65 27 09
Mouna HANACHI GUIDOUM, MD
principal investigator · Service de Nutrition Clinique, Hôpital Paul Brousse - APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion